Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis-Reference-Cited by-同舟云学术

Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis

Published:2019-10 Issue:10 Volume:20 Page:1395-1408
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Antonia Scott J,Borghaei Hossein,Ramalingam Suresh S,Horn Leora,De Castro Carpeño Javier,Pluzanski Adam,Burgio Marco A,Garassino Marina,Chow Laura Q M,Gettinger Scott,Crinò Lucio,Planchard David,Butts Charles,Drilon Alexander,Wojcik-Tomaszewska Joanna,Otterson Gregory A,Agrawal Shruti,Li Ang,Penrod John R,Brahmer Julie

Publisher

Elsevier BV

Subject

Oncology

Reference28 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. SEER Cancer Statistics Review;Noone,1975

3. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer;Brahmer;N Engl J Med,2015

4. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer;Borghaei;N Engl J Med,2015

5. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial;Herbst;Lancet,2016

Cited by 265 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-Resolution CT Patterns of Anti-PD1 Checkpoint Inhibitor-Related Pneumonitis in Patients With Lung Cancer;Journal of Computer Assisted Tomography;2024-08-12

2. Lipid-associated macrophages for osimertinib resistance and leptomeningeal metastases in NSCLC;Cell Reports;2024-08

3. Patient and Caregiver Experience With the Hope and Prognostic Uncertainty of Immunotherapy: A Qualitative Study;JCO Oncology Practice;2024-07-22

4. Understanding the treatment response and resistance to targeted therapies in non-small cell lung cancer: clinical insights and perspectives;Frontiers in Oncology;2024-07-11

5. Neuroimmune cell interactions and chronic infections in oral cancers;Frontiers in Medicine;2024-07-10